Delivery Order SPE2DB20D3104-SPE2DB24FV4U9
Award Date 1/31/24
Potential Completion Date 2/1/24
Potential Value $5.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $16,782.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,966,829 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award, valued at $1,795.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 8 mg tablets, a medication commonly used to treat nausea and vomiting. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of February 28, 2025. This award is not associated with a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,940.22 firm fixed-price delivery order is for the supply of 4 mg Ondansetron ODT tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $5,550.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 2, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $19,431.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,202,174 units of the drug Ondansetron ODT 8 mg Tablet, which is used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of May 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $1,150.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ondansetron ODT 8 mg tablets, a medication used to prevent nausea and vomiting. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 21, 2022. The contract does not have a set-aside designation, indicating it was awarded...
- This federal contract award, valued at $1,256.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,629,287 units of Ondansetron ODT 8 mg tablets, a medication used to prevent nausea and vomiting. This contract award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,923.82 firm fixed price delivery order is for ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of January 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is not associated with a set-aside program. The...
- This federal contract award, valued at $13,642.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4562303884 Ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of September 27, 2023 and is structured as a firm fixed-price delivery order. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a...
- This federal contract award, valued at $2,763.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for Ondansetron ODT 4 mg tablets, which are used to prevent nausea and vomiting. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 1, 2024. This award is not associated with a set-aside designation, indicating open...